Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017
June 20, 2017 09:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 20, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CEO Oliver Peoples, Ph.D., will be presenting today at BIO 2017 on a panel entitled:...
Innovate Biopharmaceuticals to present progress towards phase 3 celiac disease trials at BIO 2017 Convention
June 06, 2017 08:07 ET
|
Innovate Biopharmaceuticals, Inc
RALEIGH, N.C., June 06, 2017 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, a leader in developing innovative therapies for autoimmune and inflammatory diseases, will present on its phase 3 drug...